Foley Todd
Insider CIK 1473930 · ZLCS Director · CLDN Director · CHMA Director, 10% owner · CNAT 10% owner · SNDX 10% owner · PCRX · RDUS 10% owner · TRIV 10% owner · PETX 10% owner · VSTM · CERC 10% owner · EPZM 10% owner · RYTM Director, 10% owner · ONCR 10% owner · TRDA Director, 10% owner · HARP 10% owner · TCRR 10% owner · HOWL 10% owner · RPTX Director · ITOS 10% owner · DYN 10% owner · AKTS Director, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-09 | 2026-09-09 | 28,837 | $7.13 | $205.6K | 3,885,115 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-08 | 2026-09-09 | 192,500 | $7.41 | $1.43M | 3,913,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-04 | 2026-09-09 | 38,500 | $7.11 | $273.7K | 4,106,452 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-03 | 2026-09-03 | 32,263 | $7.17 | $231.3K | 4,144,952 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-02 | 2026-09-03 | 25,131 | $7.19 | $180.7K | 4,177,215 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-09-01 | 2026-09-03 | 29,088 | $7.06 | $205.4K | 4,202,346 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-31 | 2026-08-31 | 44,259 | $6.99 | $309.4K | 4,231,434 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-28 | 2026-08-31 | 3,733 | $7.01 | $26.2K | 4,275,693 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-27 | 2026-08-31 | 38,922 | $7.20 | $280.2K | 4,279,426 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-26 | 2026-08-26 | 14,569 | $7.06 | $102.9K | 4,318,348 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-25 | 2026-08-26 | 26,522 | $7.54 | $200.0K | 4,332,917 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2026-08-24 | 2026-08-26 | 21,623 | $7.34 | $158.7K | 4,359,439 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-14 | 10,227,273 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-14 | 2,727,273 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion deriv | 2026-01-12 | 2026-01-14 | 2,272,727 | — | $0 | 0 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-14 | 716,872 | — | $0 | 4,002,533 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-14 | 597,391 | — | $0 | 597,391 | SEC↗ |
| AKTS Aktis Oncology, Inc. | P Buy | 2026-01-12 | 2026-01-14 | 232,870 | $18.00 | $4.19M | 4,235,403 | SEC↗ |
| AKTS Aktis Oncology, Inc. | C Conversion | 2026-01-12 | 2026-01-14 | 2,688,270 | — | $0 | 3,285,661 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2025-05-13 | 2025-05-15 | 630,191 | $8.06 | $5.08M | 2,108,594 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise deriv | 2025-03-27 | 2025-04-30 | 18,743 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise deriv | 2025-03-27 | 2025-04-30 | 4,015 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | S Sale | 2025-03-27 | 2025-04-30 | 1,963 | $1.05 | $2.1K | 3,208,793 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | X Exercise | 2025-03-27 | 2025-04-30 | 22,758 | $0.09 | $2.0K | 3,210,756 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2024-12-11 | 2024-12-12 | 21,787 | $20.23 | $440.8K | 4,381,062 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | S Sale | 2024-12-10 | 2024-12-12 | 22,935 | $20.77 | $476.4K | 4,402,849 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2023-06-08 | 2023-06-12 | 27,200 | — | $0 | 27,200 | SEC↗ |
| TCRR TCR2 THERAPEUTICS INC. | J Other | 2023-06-01 | 2023-06-05 | 4,158,964 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2022-06-02 | 2022-06-06 | 11,918 | — | $0 | 11,918 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2022-05-13 | 2022-05-16 | 49,000 | — | $0 | 49,000 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-05 | 2022-01-06 | 18,135 | $42.03 | $762.2K | 2,738,785 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 7,671 | $46.47 | $356.5K | 2,756,920 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 6,768 | $45.32 | $306.7K | 2,764,591 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 94,745 | $42.05 | $3.98M | 2,790,725 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2022-01-04 | 2022-01-06 | 19,366 | $43.20 | $836.6K | 2,771,359 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-07 | 17,962 | $33.15 | $595.4K | 2,886,964 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-07 | 2021-12-07 | 1,494 | $34.11 | $51.0K | 2,885,470 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 60 | $35.04 | $2.1K | 2,904,926 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 508 | $34.08 | $17.3K | 2,904,986 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 8,469 | $32.35 | $274.0K | 2,906,665 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-06 | 2021-12-07 | 1,171 | $33.57 | $39.3K | 2,905,494 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 2,419 | $35.44 | $85.7K | 2,915,313 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 179 | $36.26 | $6.5K | 2,915,134 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-03 | 2021-12-07 | 17,569 | $34.68 | $609.3K | 2,917,732 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-02 | 29,757 | $33.74 | $1.00M | 2,942,731 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-02 | 2021-12-02 | 7,430 | $34.83 | $258.8K | 2,935,301 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 896 | $35.34 | $31.7K | 2,972,488 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 5,457 | $34.61 | $188.9K | 2,973,384 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-12-01 | 2021-12-02 | 6,042 | $33.82 | $204.3K | 2,978,841 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-02 | 5,861 | $34.62 | $202.9K | 3,012,959 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-30 | 2021-12-02 | 28,076 | $35.19 | $988.0K | 2,984,883 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-11-30 | 10,073 | $34.46 | $347.1K | 3,019,118 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-29 | 2021-11-30 | 298 | $35.37 | $10.5K | 3,018,820 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 6,129 | $36.03 | $220.8K | 3,029,191 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-26 | 2021-11-30 | 6,545 | $35.49 | $232.3K | 3,035,320 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 13,126 | $37.02 | $485.9K | 3,041,865 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 4,868 | $35.20 | $171.4K | 3,073,334 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-24 | 2021-11-24 | 18,343 | $36.05 | $661.3K | 3,054,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 359 | $36.50 | $13.1K | 3,078,202 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-23 | 2021-11-24 | 19,645 | $36.21 | $711.3K | 3,078,561 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 11,807 | $37.81 | $446.4K | 3,098,206 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-11-22 | 2021-11-24 | 9,307 | $37.16 | $345.8K | 3,110,013 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-11-17 | 2021-11-24 | 15,671 | — | $0 | 3,119,320 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 3,683,241 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 27,617,675 | — | $0 | 0 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 3,816,760 | — | $0 | 3,816,760 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | P Buy | 2021-11-02 | 2021-11-04 | 100,000 | $20.00 | $2.00M | 4,425,784 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 509,024 | — | $0 | 4,325,784 | SEC↗ |
| TRDA Entrada Therapeutics, Inc. | A Award deriv | 2021-10-28 | 2021-11-01 | 23,552 | — | $0 | 23,552 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-18 | 2021-10-18 | 6,167 | $27.14 | $167.4K | 3,134,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 2,039 | $28.01 | $57.1K | 3,141,158 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-15 | 2021-10-18 | 8,893 | $27.53 | $244.8K | 3,143,197 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-14 | 2021-10-14 | 27,320 | $27.30 | $745.8K | 3,152,090 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-13 | 2021-10-14 | 20,929 | $27.13 | $567.8K | 3,179,410 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-12 | 2021-10-14 | 8,521 | $27.09 | $230.8K | 3,200,339 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-11 | 2021-10-12 | 48,812 | $27.24 | $1.33M | 3,208,860 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-08 | 2021-10-12 | 2,032 | $27.01 | $54.9K | 3,257,672 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-07 | 2021-10-12 | 1,149 | $27.00 | $31.0K | 3,259,704 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-04 | 2021-10-05 | 20,711 | $27.06 | $560.4K | 3,260,853 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-10-01 | 2021-10-05 | 6,855 | $27.00 | $185.1K | 3,281,564 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-30 | 2021-09-30 | 2,292 | $27.00 | $61.9K | 3,288,419 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-28 | 2021-09-30 | 19,214 | $27.00 | $518.8K | 3,290,711 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-27 | 2021-09-27 | 11,625 | $27.09 | $314.9K | 3,309,925 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-24 | 2021-09-27 | 4,913 | $27.81 | $136.6K | 3,321,550 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 36,213 | $27.96 | $1.01M | 3,327,180 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-23 | 2021-09-27 | 717 | $28.38 | $20.3K | 3,326,463 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-22 | 2021-09-23 | 14,294 | $27.54 | $393.7K | 3,363,393 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-21 | 2021-09-23 | 19,635 | $27.47 | $539.4K | 3,377,687 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-20 | 13,701 | $27.84 | $381.4K | 3,397,322 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-20 | 2021-09-20 | 10,602 | $27.03 | $286.6K | 3,411,023 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-17 | 2021-09-20 | 45,698 | $28.82 | $1.32M | 3,421,625 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-16 | 2021-09-20 | 21,253 | $28.47 | $605.1K | 3,467,323 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 23,113 | $27.79 | $642.3K | 3,489,567 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-15 | 2021-09-16 | 991 | $28.15 | $27.9K | 3,488,576 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 17,938 | $27.50 | $493.3K | 3,516,303 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-14 | 2021-09-16 | 3,623 | $27.99 | $101.4K | 3,512,680 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-13 | 2021-09-13 | 21,384 | $27.64 | $591.1K | 3,534,241 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 6,771 | $28.73 | $194.5K | 3,555,625 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-10 | 2021-09-13 | 6,760 | $27.86 | $188.3K | 3,562,396 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-09 | 2021-09-13 | 22,725 | $28.97 | $658.3K | 3,569,156 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 940 | $29.10 | $27.4K | 3,591,881 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-08 | 2021-09-08 | 11,152 | $28.61 | $319.1K | 3,592,821 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-09-07 | 2021-09-08 | 30,474 | $29.18 | $889.2K | 3,635,313 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-09-07 | 2021-09-08 | 31,340 | — | $0 | 3,603,793 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 10,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| CHMA CHIASMA, INC | D To issuer deriv | 2021-08-05 | 2021-08-05 | 13,000 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-07-12 | 2021-07-13 | 313 | $34.10 | $10.7K | 2,242,636 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-07-12 | 2021-07-13 | 25,246 | $33.58 | $847.8K | 2,242,949 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-07-09 | 2021-07-13 | 1,792 | $33.06 | $59.2K | 2,268,195 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-29 | 2021-06-30 | 1,190 | $33.29 | $39.6K | 2,269,987 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 1,190 | $34.82 | $41.4K | 2,271,177 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-28 | 2021-06-30 | 6,080 | $34.06 | $207.1K | 2,272,367 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-25 | 2021-06-28 | 9,943 | $33.51 | $333.2K | 2,278,447 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-24 | 2021-06-28 | 2,697 | $33.53 | $90.4K | 2,288,390 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-23 | 2021-06-23 | 622 | $32.98 | $20.5K | 2,291,087 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-22 | 2021-06-23 | 189 | $34.09 | $6.4K | 2,291,709 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-22 | 2021-06-23 | 1,486 | $33.36 | $49.6K | 2,291,898 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-21 | 2021-06-23 | 2,556 | $33.80 | $86.4K | 2,307,390 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-21 | 2021-06-23 | 14,006 | $34.63 | $485.0K | 2,293,384 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-18 | 2021-06-21 | 1,410 | $34.03 | $48.0K | 2,309,946 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-18 | 2021-06-21 | 2,556 | $33.46 | $85.5K | 2,311,356 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-17 | 2021-06-21 | 753 | $34.12 | $25.7K | 2,313,912 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-17 | 2021-06-21 | 13,575 | $33.78 | $458.6K | 2,314,665 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-16 | 2021-06-16 | 1,862 | $33.33 | $62.1K | 2,328,240 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-14 | 2021-06-16 | 881 | $33.09 | $29.2K | 2,330,102 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-09 | 2021-06-10 | 10,738 | $34.79 | $373.6K | 2,330,983 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-09 | 2021-06-10 | 4,785 | $34.42 | $164.7K | 2,341,721 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-08 | 2021-06-10 | 7,559 | $33.41 | $252.5K | 2,346,506 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-08 | 2021-06-10 | 3,985 | $32.80 | $130.7K | 2,354,065 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-07 | 2021-06-07 | 1,058 | $30.74 | $32.5K | 2,367,178 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-07 | 2021-06-07 | 749 | $32.25 | $24.2K | 2,366,429 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-07 | 2021-06-07 | 8,379 | $32.96 | $276.2K | 2,358,050 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-04 | 2021-06-07 | 3,544 | $30.80 | $109.2K | 2,370,304 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-04 | 2021-06-07 | 2,068 | $31.28 | $64.7K | 2,368,236 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-03 | 2021-06-07 | 9,824 | $31.92 | $313.6K | 2,373,848 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-02 | 2021-06-02 | 130 | $32.42 | $4.2K | 2,383,672 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-02 | 2021-06-02 | 2,608 | $31.83 | $83.0K | 2,383,802 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-06-01 | 2021-06-02 | 6,671 | $32.50 | $216.8K | 2,386,410 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-28 | 2021-06-02 | 7,377 | $32.67 | $241.0K | 2,393,081 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-27 | 2021-05-27 | 1,597 | $33.16 | $53.0K | 2,400,458 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-27 | 2021-05-27 | 1,906 | $32.81 | $62.5K | 2,402,055 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-26 | 2021-05-27 | 751 | $33.01 | $24.8K | 2,403,961 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-26 | 2021-05-27 | 9,839 | $32.74 | $322.1K | 2,404,712 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-25 | 2021-05-27 | 44 | $33.59 | $1.5K | 2,414,551 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-25 | 2021-05-27 | 2,852 | $32.87 | $93.7K | 2,414,595 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-24 | 2021-05-24 | 8,219 | $34.28 | $281.7K | 2,417,447 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-24 | 2021-05-24 | 1,563 | $33.30 | $52.0K | 2,425,666 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-21 | 2021-05-24 | 133,359 | $34.80 | $4.64M | 2,427,229 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-20 | 2021-05-20 | 4,122 | $34.66 | $142.9K | 2,560,853 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-20 | 2021-05-20 | 265 | $35.19 | $9.3K | 2,560,588 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-19 | 2021-05-20 | 1,939 | $35.00 | $67.9K | 2,564,975 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-19 | 2021-05-20 | 4,029 | $34.23 | $137.9K | 2,566,914 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-05-18 | 2021-05-20 | 21,834 | — | $0 | 2,570,943 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-18 | 2021-05-20 | 40 | $35.14 | $1.4K | 2,592,777 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-18 | 2021-05-20 | 3,763 | $34.61 | $130.2K | 2,592,817 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-05-18 | 2021-05-20 | 6,509 | $33.90 | $220.7K | 2,596,580 | SEC↗ |
| RPTX Repare Therapeutics Inc. | A Award deriv | 2021-05-13 | 2021-05-14 | 21,000 | — | $0 | 21,000 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-06 | 6,621,546 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion deriv | 2021-05-04 | 2021-05-06 | 19,925,321 | — | $0 | 0 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-06 | 2,298,430 | — | $0 | 2,298,430 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | P Buy | 2021-05-04 | 2021-05-06 | 125,759 | $16.00 | $2.01M | 3,187,998 | SEC↗ |
| HOWL Werewolf Therapeutics, Inc | C Conversion | 2021-05-04 | 2021-05-06 | 763,809 | — | $0 | 3,062,239 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-15 | 2021-04-15 | 1,052 | $20.49 | $21.6K | 3,220,844 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-14 | 2021-04-15 | 1,550 | $20.83 | $32.3K | 3,221,896 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-14 | 2021-04-15 | 121 | $20.06 | $2.4K | 3,223,446 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-13 | 2021-04-15 | 286 | $20.08 | $5.7K | 3,223,567 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-13 | 2021-04-15 | 1,657 | $19.35 | $32.1K | 3,223,853 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 48 | $22.68 | $1.1K | 3,225,510 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 1,637 | $20.72 | $33.9K | 3,226,369 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-12 | 2021-04-13 | 811 | $21.52 | $17.5K | 3,225,558 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 10,300 | $23.67 | $243.8K | 3,228,006 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-09 | 2021-04-13 | 119 | $29.99 | $3.6K | 3,665,787 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 19,057 | $30.51 | $581.4K | 3,666,153 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-08 | 2021-04-09 | 247 | $31.01 | $7.7K | 3,655,906 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 1,842 | $32.84 | $60.5K | 3,701,657 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 777 | $33.84 | $26.3K | 3,700,880 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | S Sale | 2021-04-07 | 2021-04-09 | 3,164 | $32.07 | $101.5K | 3,703,499 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | J Other | 2021-04-07 | 2021-04-09 | 15,670 | — | $0 | 3,685,210 | SEC↗ |
| RPTX Repare Therapeutics Inc. | J Other | 2021-03-15 | 2021-03-15 | 24,271 | — | $0 | 2,603,089 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2021-03-15 | 2021-03-16 | 1,000,000 | $25.10 | $25.10M | 909,258 | SEC↗ |
| RPTX Repare Therapeutics Inc. | S Sale | 2021-03-12 | 2021-03-15 | 376,412 | $28.18 | $10.61M | 2,627,360 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-10 | 2021-02-12 | 183,051 | $20.00 | $3.66M | 3,238,306 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-09 | 2021-02-09 | 9,400 | $20.25 | $190.3K | 3,421,357 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-08 | 2021-02-09 | 72,128 | $20.04 | $1.45M | 3,430,757 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-05 | 2021-02-09 | 10,172 | $20.01 | $203.5K | 3,502,885 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-04 | 2021-02-04 | 29,730 | $20.37 | $605.6K | 3,513,057 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-03 | 2021-02-04 | 41,922 | $20.21 | $847.2K | 3,542,787 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-02-02 | 2021-02-04 | 48,421 | $20.13 | $974.7K | 3,584,709 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-27 | 2021-01-27 | 706,825 | $20.00 | $14.14M | 3,633,130 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-26 | 2021-01-27 | 1,363 | $21.08 | $28.7K | 4,339,955 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-25 | 2021-01-27 | 13,006 | $21.23 | $276.1K | 4,341,318 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-22 | 2021-01-22 | 24,695 | $21.72 | $536.4K | 4,354,324 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-22 | 20,979 | $22.11 | $463.8K | 4,384,106 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-22 | 200 | $23.77 | $4.8K | 4,379,019 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-21 | 2021-01-22 | 4,887 | $22.61 | $110.5K | 4,379,219 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | J Other | 2021-01-20 | 2021-01-22 | 101,646 | — | $0 | 4,405,085 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 2,000 | $24.71 | $49.4K | 4,506,731 | SEC↗ |
| HARP Harpoon Therapeutics, Inc. | S Sale | 2021-01-20 | 2021-01-22 | 15,694 | $23.95 | $375.9K | 4,508,731 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion deriv | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 0 | SEC↗ |
| ONCR Oncorus, Inc. | P Buy | 2020-10-06 | 2020-10-08 | 173,776 | $15.00 | $2.61M | 2,849,453 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 1,783,879 | — | $0 | 1,899,702 | SEC↗ |
| ONCR Oncorus, Inc. | C Conversion | 2020-10-06 | 2020-10-08 | 775,975 | — | $0 | 2,675,677 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 743,076 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 275,932 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 26,176 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 70,492 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 13,980,992 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion deriv | 2020-09-21 | 2020-09-23 | 1,326,313 | — | $0 | 0 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 245,279 | — | $0 | 245,279 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 91,081 | — | $0 | 91,081 | SEC↗ |
| DYN Dyne Therapeutics, Inc. | C Conversion | 2020-09-21 | 2020-09-23 | 4,614,943 | — | $0 | 4,614,943 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 255,094 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 3,824,591 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 131,645 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 2,415,530 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 128,384 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 47,674 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 29,440 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 79,281 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 1,491,666 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 81,295 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 157,529 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion deriv | 2020-07-28 | 2020-07-29 | 2,361,805 | — | $0 | 0 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 724,702 | — | $0 | 1,993,932 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 1,269,230 | — | $0 | 1,269,230 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 84,655 | — | $0 | 84,655 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 43,687 | — | $0 | 43,687 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 801,619 | — | $0 | 801,619 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 42,605 | — | $0 | 42,605 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 15,820 | — | $0 | 15,820 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 48,336 | — | $0 | 132,991 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 24,944 | — | $0 | 68,381 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 457,706 | — | $0 | 1,259,325 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 24,326 | — | $0 | 66,931 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | C Conversion | 2020-07-28 | 2020-07-29 | 9,033 | — | $0 | 24,853 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 89,955 | $19.00 | $1.71M | 2,083,887 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 5,994 | $19.00 | $113.9K | 138,985 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 3,096 | $19.00 | $58.8K | 71,727 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 56,814 | $19.00 | $1.08M | 1,316,139 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 3,020 | $19.00 | $57.4K | 69,951 | SEC↗ |
| ITOS iTeos Therapeutics, Inc. | P Buy | 2020-07-28 | 2020-07-29 | 1,121 | $19.00 | $21.3K | 25,974 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-06-26 | 2020-06-30 | 300 | $25.04 | $7.5K | 1,909,258 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-06-25 | 2020-06-25 | 17,947 | $25.41 | $456.0K | 1,909,558 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-06-24 | 2020-06-25 | 97,388 | $25.34 | $2.47M | 1,927,505 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 1,801,581 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion deriv | 2020-06-23 | 2020-06-25 | 952,191 | — | $0 | 0 | SEC↗ |
| RPTX Repare Therapeutics Inc. | P Buy | 2020-06-23 | 2020-06-25 | 250,000 | $20.00 | $5.00M | 3,003,772 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 1,801,581 | — | $0 | 1,801,581 | SEC↗ |
| RPTX Repare Therapeutics Inc. | C Conversion | 2020-06-23 | 2020-06-25 | 952,191 | — | $0 | 2,753,772 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | A Award deriv | 2020-06-17 | 2020-06-18 | 18,500 | — | $0 | 18,500 | SEC↗ |
| CHMA CHIASMA, INC | A Award deriv | 2020-06-11 | 2020-06-12 | 13,000 | — | $0 | 13,000 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-06-05 | 2020-06-05 | 1,896 | $20.00 | $37.9K | 2,024,893 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-06-03 | 2020-06-03 | 18,245 | $20.27 | $369.8K | 2,026,789 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-06-02 | 2020-06-03 | 15,578 | $20.23 | $315.1K | 2,045,034 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-06-01 | 2020-06-03 | 10,535 | $20.08 | $211.5K | 2,060,612 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-28 | 2020-05-28 | 19,152 | $20.19 | $386.7K | 2,071,147 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-27 | 2020-05-28 | 10,148 | $20.13 | $204.3K | 2,090,299 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-26 | 2020-05-26 | 44,421 | $20.47 | $909.3K | 2,100,447 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-22 | 2020-05-26 | 26,906 | $20.13 | $541.6K | 2,144,868 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-21 | 2020-05-26 | 25,594 | $20.25 | $518.3K | 2,171,774 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-20 | 2020-05-20 | 10,527 | $20.01 | $210.6K | 2,197,368 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-19 | 2020-05-20 | 2,633 | $20.00 | $52.7K | 2,207,895 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-18 | 2020-05-20 | 21,349 | $20.00 | $427.0K | 2,210,528 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-13 | 2020-05-15 | 1,837 | $20.04 | $36.8K | 2,231,877 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-12 | 2020-05-12 | 24,342 | $20.23 | $492.4K | 2,233,714 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-11 | 2020-05-12 | 22,155 | $20.34 | $450.6K | 2,258,056 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-08 | 2020-05-12 | 6,633 | $20.05 | $133.0K | 2,280,211 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-07 | 2020-05-07 | 200 | $20.01 | $4.0K | 2,286,844 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-05-06 | 2020-05-07 | 1,626 | $20.00 | $32.5K | 2,287,044 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-04-29 | 2020-04-30 | 20,397 | $20.12 | $410.4K | 2,288,670 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-04-28 | 2020-04-30 | 15,826 | $20.07 | $317.6K | 2,309,067 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-04-01 | 2020-04-01 | 15,462 | $15.10 | $233.5K | 2,324,893 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-03-31 | 2020-04-01 | 19,108 | $15.16 | $289.7K | 2,340,355 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-03-26 | 2020-03-30 | 2,300 | $15.04 | $34.6K | 2,359,463 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-03-20 | 2020-03-24 | 1,100 | $15.00 | $16.5K | 2,361,763 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-03-19 | 2020-03-19 | 8,200 | $15.07 | $123.6K | 2,362,863 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-03-18 | 2020-03-19 | 12,781 | $15.14 | $193.5K | 2,371,063 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2020-03-17 | 2020-03-19 | 9,653 | $15.12 | $146.0K | 2,383,844 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-12-12 | 2019-12-13 | 3,762 | $25.01 | $94.1K | 2,393,497 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-12-11 | 2019-12-13 | 13,600 | $25.14 | $341.9K | 2,397,259 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-12-10 | 2019-12-11 | 41,839 | $25.36 | $1.06M | 2,410,859 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-12-09 | 2019-12-11 | 22,195 | $25.04 | $555.8K | 2,452,698 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-12-03 | 2019-12-03 | 16,777 | $22.33 | $374.6K | 2,474,893 | SEC↗ |
| RYTM RHYTHM PHARMACEUTICALS, IN | S Sale | 2019-12-02 | 2019-12-03 | 25,366 | $22.03 | $558.8K | 2,491,670 | SEC↗ |